Table 1.

Kinetic of 3DO Apoptosis and Activation

Groups % Apoptosis Fas (median) FasL (%) IL-2 (pg/mL) IL2R+ (%)
Control  1.8  12.6  1.2 Neg  Neg  
Anti-CD3 (1 h)  2.1  13.1  2.2 Neg  Neg  
Anti-CD3 (4 h)  2.5  13.8  1.3 Neg  Neg  
Anti-CD3 (8 h)  7.5  16.5  106.4  25  
Anti-CD3 (18 h)  40  38.5  58.5* 702 63 
Groups % Apoptosis Fas (median) FasL (%) IL-2 (pg/mL) IL2R+ (%)
Control  1.8  12.6  1.2 Neg  Neg  
Anti-CD3 (1 h)  2.1  13.1  2.2 Neg  Neg  
Anti-CD3 (4 h)  2.5  13.8  1.3 Neg  Neg  
Anti-CD3 (8 h)  7.5  16.5  106.4  25  
Anti-CD3 (18 h)  40  38.5  58.5* 702 63 

3DO cells were cultured for different times in 96-well plates coated with anti-CD3 MoAb (1 μg/mL). Results are expressed as the percentage of apoptotic nuclei, the median of Fas expression histogram, the percentage of FasL+ cells, the amount of IL-2 in pg/mL, the percentage of IL-2R+ cells, and are the means of three separate experiments. The standard errors (<10%) are omitted for clarity.

*

Blocking peptide, at a concentration 10-fold higher then anti-FasL antibody was used, in two experiments, to control the specificity of the staining. Addition of the peptide inhibited the FasL staining down to 2.1% (first experiment) and 2.6% (second experiment), respectively, compared with anti-CD3 (18 h)-treated cells giving 57.2% (first experiment) and 58% (second experiment).